Qube Research & Technologies LTD Adma Biologics, Inc. Transaction History

Qube Research & Technologies LTD

  • $93.8 Billion
  • Q2 2025

A detailed history of Qube Research & Technologies LTD transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 289,185 shares of ADMA stock, worth $4.48 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
289,185
Previous 247,486 16.85%
Holding current value
$4.48 Million
Previous $4.91 Million 7.25%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$17.6 - $24.51 $733,902 - $1.02 Million
41,699 Added 16.85%
289,185 $5.27 Million
Q1 2025

May 15, 2025
SELL
$15.44 - $20.61 $5.49 Million - $7.32 Million
-355,281 Reduced 58.94%
247,486 $4.91 Million
Q4 2024

Feb 14, 2025
BUY
$15.62 - $22.62 $4.6 Million - $6.67 Million
294,685 Added 95.65%
602,767 $10.3 Million
Q3 2024

Nov 14, 2024
SELL
$11.21 - $20.03 $1.21 Million - $2.17 Million
-108,339 Reduced 26.02%
308,082 $6.16 Million
Q2 2024

Aug 14, 2024
BUY
$5.98 - $11.18 $1.36 Million - $2.55 Million
228,077 Added 121.1%
416,421 $4.66 Million
Q1 2024

May 14, 2024
SELL
$4.4 - $6.74 $2.57 Million - $3.93 Million
-583,127 Reduced 75.59%
188,344 $1.24 Million
Q4 2023

Feb 13, 2024
SELL
$3.08 - $4.52 $1.33 Million - $1.96 Million
-433,177 Reduced 35.96%
771,471 $3.49 Million
Q3 2023

Nov 13, 2023
BUY
$3.47 - $4.61 $779,695 - $1.04 Million
224,696 Added 22.93%
1,204,648 $4.31 Million
Q2 2023

Aug 14, 2023
BUY
$3.12 - $4.22 $1.39 Million - $1.88 Million
444,455 Added 83.0%
979,952 $3.62 Million
Q1 2023

May 15, 2023
BUY
$3.01 - $3.87 $1.49 Million - $1.91 Million
493,424 Added 1172.78%
535,497 $1.77 Million
Q4 2022

Feb 14, 2023
SELL
$2.47 - $3.88 $619,698 - $973,453
-250,890 Reduced 85.64%
42,073 $163,000
Q3 2022

Nov 14, 2022
BUY
$2.03 - $2.86 $594,714 - $837,874
292,963 New
292,963 $712,000
Q2 2022

Aug 15, 2022
SELL
$1.43 - $2.2 $211,754 - $325,776
-148,080 Closed
0 $0
Q1 2022

May 09, 2022
BUY
$1.28 - $1.83 $55,705 - $79,641
43,520 Added 41.62%
148,080 $271,000
Q4 2021

Feb 01, 2022
BUY
$1.09 - $1.66 $101,122 - $154,003
92,773 Added 787.08%
104,560 $147,000
Q3 2021

Nov 12, 2021
SELL
$1.13 - $1.65 $136,504 - $199,320
-120,800 Reduced 91.11%
11,787 $13,000
Q2 2021

Aug 13, 2021
BUY
$1.51 - $2.07 $145,559 - $199,541
96,397 Added 266.36%
132,587 $212,000
Q1 2021

May 14, 2021
BUY
$1.67 - $2.95 $60,437 - $106,760
36,190 New
36,190 $64,000
Q3 2020

Nov 12, 2020
SELL
$2.04 - $3.74 $72,560 - $133,028
-35,569 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$2.42 - $3.29 $86,076 - $117,022
35,569 New
35,569 $104,000

Others Institutions Holding ADMA

# of Institutions
397
Shares Held
191M
Call Options Held
2.08M
Put Options Held
1.56M
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.04B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email